Literature DB >> 12821115

Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies.

Masafumi Nakayama1, Norihiro Harada, Ko Okumura, Hideo Yagita.   

Abstract

In the present study, we characterized murine TWEAK and its receptor (Fn14) by generating cDNA transfectants and specific monoclonal antibodies (mAbs). Recombinant murine TWEAK bound to murine Fn14-transfected L5178Y (mFn14/L5178Y) cells and induced cell death. Some anti-human Fn14 mAbs we previously generated strongly cross-reacted with murine Fn14 and induced cell death in mFn14/L5178Y cells. Murine TWEAK-transfected L5178Y cells expressed murine TWEAK on cell surface and secreted functional TWEAK, which were detected by a newly generated anti-murine TWEAK mAb (MTW-1). Although thioglycolate-elicited murine peritoneal macrophages did not express a detectable level of TWEAK on their surface, they secreted functional TWEAK that was cytotoxic against mFn14/L5178Y cells and neutralized by MTW-1. The anti-murine TWEAK and Fn14 mAbs will be useful for further investigating the physiological and pathological functions of TWEAK and Fn14.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12821115     DOI: 10.1016/s0006-291x(03)01051-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

1.  Full-length, membrane-anchored TWEAK can function as a juxtacrine signaling molecule and activate the NF-kappaB pathway.

Authors:  Sharron A N Brown; Arundhati Ghosh; Jeffrey A Winkles
Journal:  J Biol Chem       Date:  2010-04-12       Impact factor: 5.157

2.  The role of tumor necrosis factor-like weak inducer of apoptosis in atherosclerosis via its two different receptors.

Authors:  Hengdao Liu; Dan Lin; Hong Xiang; Wei Chen; Shaoli Zhao; Hui Peng; Jie Yang; Pan Chen; Shuhua Chen; Hongwei Lu
Journal:  Exp Ther Med       Date:  2017-06-14       Impact factor: 2.447

3.  The interplay between surfaces and soluble factors define the immunologic and angiogenic properties of myeloid dendritic cells.

Authors:  Leslee Sprague; Maria Muccioli; Michelle Pate; Evan Meles; John McGinty; Harika Nandigam; Amritha K Venkatesh; Ming-Yu Gu; Kristen Mansfield; Andrew Rutowski; Omowaleola Omosebi; Maria C Courreges; Fabian Benencia
Journal:  BMC Immunol       Date:  2011-06-06       Impact factor: 3.615

4.  Therapeutic potential of the TWEAK/Fn14 pathway in intractable gastrointestinal cancer.

Authors:  Ryo Yoriki; Satoru Akashi; Masayuki Sho; Takeo Nomi; Ichiro Yamato; Kiyohiko Hotta; Tomoyoshi Takayama; Sohei Matsumoto; Kohei Wakatsuki; Kazuhiro Migita; Hideo Yagita; Yoshiyuki Nakajima
Journal:  Exp Ther Med       Date:  2010-12-02       Impact factor: 2.447

5.  Adhesion to substrates induces dendritic cell endothelization and decreases immunological response.

Authors:  Jacob Osterbur; Leslee Sprague; Maria Muccioli; Michelle Pate; Kristen Mansfield; John McGinty; Yihan Li; Yandi Li; Venktesh Shirure; Maria Cecilia Courreges; Fabian Benencia
Journal:  Immunobiology       Date:  2012-02-27       Impact factor: 3.144

6.  Development of an Fn14 agonistic antibody as an anti-tumor agent.

Authors:  Jennifer S Michaelson; Aldo Amatucci; Rebecca Kelly; Lihe Su; Ellen Garber; Eric S Day; Lisa Berquist; Sandy Cho; You Li; Michael Parr; Laure Wille; Pascal Schneider; Kathleen Wortham; Linda C Burkly; Yen-Ming Hsu; Ingrid B J K Joseph
Journal:  MAbs       Date:  2011-07-01       Impact factor: 5.857

7.  The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice.

Authors:  Ashwani Mittal; Shephali Bhatnagar; Akhilesh Kumar; Estelle Lach-Trifilieff; Sandrine Wauters; Hong Li; Denys Y Makonchuk; David J Glass; Ashok Kumar
Journal:  J Cell Biol       Date:  2010-03-22       Impact factor: 10.539

8.  The cytokine TWEAK modulates renal tubulointerstitial inflammation.

Authors:  Ana Belen Sanz; Pilar Justo; Maria Dolores Sanchez-Niño; Luis Miguel Blanco-Colio; Jeffrey A Winkles; Matthias Kreztler; Aniela Jakubowski; Julia Blanco; Jesús Egido; Marta Ruiz-Ortega; Alberto Ortiz
Journal:  J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 10.121

Review 9.  The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting.

Authors:  Jeffrey A Winkles
Journal:  Nat Rev Drug Discov       Date:  2008-05       Impact factor: 84.694

10.  Myxoma Virus Induces Ligand Independent Extrinsic Apoptosis in Human Myeloma Cells.

Authors:  Mee Y Bartee; Katherine M Dunlap; Eric Bartee
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2015-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.